July 1, 2015
BioMotiv Creates Sujana Biotech
BioMotiv has formed Sujana Biotech, a new biopharmaceutical company to commercialize technologies for the treatment of inflammatory and vascular disorders. In addition, Sujana Biotech raised $800,000 of a potential $5 million round.
Read More >